|
|
|
|
|
|
By AR Welch, Editorial & Community Director, Advancing RNA | In the first- of this three-part article series, several mRNA execs share their perspectives on the world of partnering in the RNA therapeutics space, assessing first the current state of CDMO partnerships and how they anticipate this critical supportive infrastructure will grow in the years ahead. |
|
|
|
By Antony Hitchcock, principal and owner, AGH Bioconsulting | FDA's draft guidance on platforms is mostly for established, well-characterized modalities, but it also has implications for the emerging area of personalized medicine. |
|
|
|
| Ophthalmic Drug Delivery | Article | By Dr. Tamas Solymosi, Nanoform | Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems. |
|
|
| Integrated Solutions For Advanced Therapies | White Paper | Catalent | The right CDMO offering integrated services can ease increasingly common CGT manufacturing problems such as scale, raw material access, viral vector production, and quality requirements. |
|
|
| Manufacturing Strategies For mRNA Vaccines And Therapeutics | White Paper | By Laurens Vergauwen, Dr. Nargisse El Hajjami, et al., MilliporeSigma | mRNA has emerged as a promising modality offering a great deal of versatility for a wide range of therapeutics and vaccines with its use of non-viral delivery systems. |
|
|
|
| cGMP Assurance of Supply Services | Case Study | Thermo Fisher Scientific | Explore the stocking solution offered to a mid-sized CDMO in need of a high volume of safety stock inventory to support their customer portfolio growth. |
|
|
| Methods for mRNA Poly(A) Sizing | Poster | By L. Hinkel, R. Williams, C. Herren, and T. Legan, Vernal Biosciences | This study used Oxford Nanopore Technologies' Direct RNA Sequencing Kit and obtained successful sizing of poly(A) tail regions. The results are presented in a histogram and table format. |
|
|
|
| Defining A Process For Your Unique mRNA | Infographic | Sartorius | Define a process for your unique mRNA with this interactive guide to pDNA, mRNA, and LNP. Overcome challenges with solutions that can help you develop a next-generation production strategy. |
|
|
|
| PDA Universe of Pre-Filled Syringes and Injection Devices Conference 2024 | The premier event on pre-filled syringes and injection devices brings together key field players to discuss the breakthroughs that are propelling the industry forward. A comprehensive agenda covers critical topics, including sustainability, large-volume injections, digital health, and regulatory compliance. Additionally, the exhibit hall featuring 120+ exhibitors, poster presentations, lightning sessions, lively Q&As, networking activities, and Drug Delivery Innovation Awards make this event a must-attend. |
|
|
.png){kind=logo}
